Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area

Life Sci. 1984 Jun 11;34(24):2419-27. doi: 10.1016/0024-3205(84)90431-4.

Abstract

Neuronal activity was recorded from the ventral tegmental area (VTA) of immobilized, locally anesthetized rats on the day immediately following long-term treatment (twice daily for 6 consecutive days) with saline, 1.0 or 5.0 mg/kg d-amphetamine (d-AMPH). Each rat was challenged intravenously with d-AMPH (beginning with 0.0625 mg/kg) or with 0.005 mg/kg apomorphine. Treatment with d-AMPH significantly reduced the ability of this drug to inhibit VTA activity. In fact, nearly half of the neurons in the high-dose treatment group were excited by d-AMPH, whereas only 20% of control neurons showed this response. Moreover, apomorphine routinely accelerated firing rate in the VTA following treatment with 5.0 mg/kg d-AMPH but this response was never observed in control neurons, not even in those that were excited by d-AMPH. Thus, tolerance appears to develop to the ability of dopamine agonists to inhibit VTA activity and this effect may be mediated, at least in part, by a subsensitivity of inhibitory dopamine autoreceptors.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Action Potentials / drug effects
  • Animals
  • Apomorphine / antagonists & inhibitors
  • Dextroamphetamine / pharmacology*
  • Dopamine / physiology*
  • Dopamine Antagonists
  • Drug Tolerance
  • Haloperidol / pharmacology
  • Male
  • Neurons / drug effects*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Dopamine / drug effects
  • Tegmentum Mesencephali / cytology
  • Tegmentum Mesencephali / drug effects*
  • Time Factors

Substances

  • Dopamine Antagonists
  • Receptors, Dopamine
  • Haloperidol
  • Apomorphine
  • Dextroamphetamine
  • Dopamine